🌳 任务树 🛠 任务管理 📄 全部 tiddler

#aging

重编程中的 senescence 可能是阶段依赖而非单向有害 20260425170201000
单一组织内 senescence 负担态与生态位态的可证伪判别框架 20260425165902000
ER stress UPR not yet baseline-positive as a mammalian longevity node 20260425154643000
Heat-shock/chaperone augmentation is not yet baseline-positive as a mammalian longevity node 20260425154317000
Proteasome augmentation is not yet baseline-positive as a longevity node 20260425154052000
不要把整类机制一刀切地排除 20260425153833000
Mitochondrial interventions have direct lifespan-endpoint positives, but evidence is heterogeneous 20260425153808000
Autophagy enhancement is not yet baseline-positive like rapamycin/mTOR 20260425153601000
Rapamycin is a baseline-positive specific node; autophagy and mitochondria are not automatically longevity candidates 20260425153226000
候选筛选要用“干预 + 终点”双约束检索 20260425152851000
mTOR/rapamycin 优先于泛化自噬/线粒体作为长寿候选 20260425152830000
IL-11 的寿命/健康寿命效应大小与证据边界 20260425152333000
IL-11 抑制的成年哺乳动物证据层级 20260425152029000
IL-11 修复代价的直接成人哺乳动物原始反例仍未检出 20260425151726000
Adult-mammal IL-11 inhibition: direct bone-homeostasis harm, fracture/wound evidence still missing 20260425151443000
IL-11 longevity benefit must be decomposed into immune/inflammatory and tissue-tradeoff components 20260425150607000
IL-11 currently ranks above other screened immune/inflammation axes because it has direct mammalian healthspan/lifespan evidence 20260425150330000
补体级联仍未跨过通用长寿瓶颈门槛 20260425150146000
IL-1/MyD88 outranks TNF/IL-6 as an upstream screening candidate, but not as a universal bottleneck 20260425145846000
Complement cascade remains a high-potential but not yet universal longevity bottleneck 20260425145530000
TNF/IL-6 are low-priority control axes in longevity bottleneck screening 20260425145355000
cGAS-STING is a strong but context-dependent aging node, not yet a universal longevity bottleneck 20260425145335000
type I interferon / JAK-STAT is an upstream amplifier, not a default universal longevity bottleneck 20260425145224000
Thymic source restoration is a strong immune upstream entry, but not yet a universal longevity bottleneck 20260425144604000
TNF/IL-6 are context-specific inflammaging mediators, not universal longevity bottlenecks 20260425144110000
cGAS-STING is an upstream inflammaging amplifier, but not yet a universal longevity bottleneck 20260425143829000
NLRP3 is a strong aging node but still not clearly a universal longevity bottleneck 20260425143408000
complement 轴是高潜力候选但尚非 universal longevity bottleneck 20260425143032000
IL-11 longevity candidacy must be split by tissue-specific tradeoffs 20260425142558000
IL-1 is a strong upstream hematopoietic inflammaging loop, but not yet a universal longevity bottleneck 20260425142133000
IL-11 inhibition: bone-homeostasis evidence is direct, fracture-healing evidence remains missing 20260425135719000
Adult-mammal IL-11 inhibition has clear bone-homeostasis consequences, but direct fracture/wound inhibition evidence is sparse 20260425135357000
IL-11 still needs a pleiotropy tradeoff audit before universal-bottleneck promotion 20260425134905000
IL-6 trans-signaling is a plausible inflammaging axis, but not a universal longevity bottleneck 20260425134712000
IgG/FcRn is a strong immune age-amplifying axis, but not yet a universal longevity bottleneck 20260425134301000
IL-1 outranks TNF and type I IFN as an upstream immune loop, but still falls short of a universal longevity bottleneck 20260425133745000
IL-11 is a strong candidate but not yet a universal bottleneck 20260425133514000
反证优先于升级候选 20260425133423000
IL-17 / Th17 is a context-dependent inflammaging axis, not a universal longevity bottleneck 20260425133233000
IL-11 remains the current top immune/inflammation longevity candidate, but not yet a universal bottleneck 20260425132624000
C1q brain aging mechanism is informative but still insufficient for universal longevity candidacy 20260425131714000
寿命终点优先于通路热度 20260425131208000
IL-11 is currently the strongest immune/inflammation longevity candidate in the screening set 20260425131144000
IgG is a strong age-amplifying node, but not yet a universal longevity bottleneck 20260425130909000
Antibody / IgG accumulation is a strong age-amplifying node, but not yet a universal longevity bottleneck 20260425130643000
trained immunity is a functional defense amplifier, not a higher-priority longevity bottleneck than thymic source restoration 20260425130412000
IL-1 / emergency myelopoiesis is upstream of aged HSC bias, but not yet a universal longevity bottleneck 20260425125943000
type I interferon / JAK-STAT chronic activation is strong but context-dependent, not yet a universal bottleneck 20260425125646000
C1q is aging-associated but not yet a universal longevity bottleneck 20260425125313000
IL-11 is a strong lifespan-positive inflammaging node, but still not yet a universal immune bottleneck 20260425124410000
FGF21 不是通用免疫长寿瓶颈，而是局部胸腺 niche 入口 20260425123837000
NLRP3 is context-dependent longevity-positive, not yet a universal bottleneck 20260425051109000
单组织寿命正例不足以把炎症轴抬升为通用长寿瓶颈 20260425050954000
按因果广度而不是表面上游性来排长寿瓶颈 20260425050740000
HSC/髓系偏置尚不能压过胸腺源恢复的免疫长寿排序 20260425050727000
局部语境决定抗衰老信号是否成立 20260425050544000
Source-restoration immune entries outrank peripheral T-cell quality control when only the former has healthspan extension 20260425050521000
Mature T-cell quality control usually ranks below thymic source restoration as a longevity entry 20260425050406000
免疫长寿入口的上游性排序 20260425050322000
免疫长寿入口的上游性排序：补给源 > 外周质量控制 > 局部 niche 维护 20260425050257000
Peripheral T-cell quality control can reach frailty, but not yet lifespan 20260425050159000
Peripheral T-cell quality control can reach frailty, while thymic regeneration remains mainly immune-readout level 20260425044850000
T-cell Bcl-xL is a concrete peripheral quality-control example, but still not a validated universal longevity bottleneck 20260425044154000
Peripheral lymph node niche repair is a lower-rank immune rejuvenation entry than thymic regeneration 20260425043703000
Peripheral lymph node niche is a reversible immune entry, but not yet higher-leverage than thymic involution 20260425043458000
Thymic involution remains the strongest reversible immune entry, but not yet a validated longevity bottleneck 20260425042531000
IL-1 emergency myelopoiesis is upstream but not yet validated as a longevity bottleneck 20260425042245000
Trained immunity is not yet a validated longevity bottleneck 20260425042105000
把 inflammaging 当作回路读出而非单一瓶颈 20260425041935000
Inflammaging is better treated as a heterogeneous readout than a universal upstream bottleneck 20260425041919000
Thymus regeneration improves immune readouts but not yet lifespan evidence 20260425041751000
Immune rejuvenation can improve systemic aging phenotypes via thymic or peripheral routes 20260425041629000
Immune interventions can improve systemic aging phenotypes, but not always via thymic regeneration 20260425041447000
Immune longevity candidate ranking: thymic involution first, readouts later 20260425041227000
优先寻找“可逆上游入口”而不是只看年龄读出 20260425041000000
Thymic involution can be experimentally reversed to restore naive T-cell output in aged mice 20260425040945000
Inflammaging 更应默认按 context-dependent readout 处理 20260425040831000
Netrin-1 可作为老化骨髓 niche 的可逆上游杠杆 20260425040329000
Blood-aging candidate ranking: HSC exhaustion over CHIP; cell competition as framework 20260425040156000
先把 cell competition 当作框架，而不是立刻当作靶点 20260425040109000
cell competition is a generic tissue-level quality-control framework 20260425040057000
老化干预要先找反馈回路 20260425035910000
Bone marrow niche rejuvenation can restore aged HSC fitness 20260425035840000
年龄相关克隆现象优先视为读出而非总瓶颈 20260425035640000
CHIP 更适合作为 HSC aging 的读出而非单一上游瓶颈 20260425035624000
CDKN2A-OSK 在皮肤创面中的 FOSL1/迁移信号更应默认按间接效应解释 20260425035159000
CDKN2A-OSK 在人皮肤创面中的直接效应与微环境间接效应应分层判断 20260425034935000
FOSL1 不能被当成 CDKN2A-OSK 直接驱动角质形成细胞迁移的证据 20260425034652000
CDKN2A-OSK 在人皮肤伤口边缘更像编辑炎症/应激状态，而非直接的增殖开关 20260425034427000
重编程效应要拆成炎症编辑与增殖激活两条轴 20260425034206000
partial reprogramming 在人皮肤修复中更像炎症/应激状态编辑，而非增殖开关 20260425034137000
partial reprogramming 在皮肤修复中更像炎症/应激状态编辑 20260425033952000
把干预时窗对齐到修复亚阶段 20260425033646000
human skin wound-healing roadmap cleanly separates acute-support and chronic-failure programs 20260425033600000
chronic wound failure programs clarify which senescence states are pathological 20260425033027000
acute skin wound healing contains distinct senescent subpopulations with opposite effects 20260425032856000
acute cutaneous wound healing is a clear example of context-dependent senescence 20260425032612000
senolysis 可能破坏有益的再生 niche 20260425032437000